Possible Contribution of Multiple Sclerosis Pathology to Treatment‐Resistant Schizophrenia: A Case Study
Clinicians should consider the possibility of comorbid MS in patients with treatment‐resistant schizophrenia, particularly when atypical clinical or neurological features are present.